Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 6,283,000 | 5,624,000 | 3,476,000 | 2,919,000 | 2,673,000 |
| Cost of Goods | 1,386,000 | 1,292,000 | 961,000 | 870,000 | 919,000 |
| Gross Profit | 4,897,000 | 4,332,000 | 2,515,000 | 2,049,000 | 1,754,000 |
| Operating Expenses | 3,929,000 | 2,758,000 | 1,818,000 | 1,439,000 | 1,654,000 |
| Operating Income | 968,000 | 1,574,000 | 697,000 | 610,000 | 100,000 |
| Interest Expense | 90,000 | 64,000 | 46,000 | 43,000 | 59,000 |
| Other Income | 13,000 | -16,000 | -8,000 | -18,000 | 3,000 |
| Pre-tax Income | 891,000 | 1,494,000 | 643,000 | 549,000 | 44,000 |
| Income Tax | 263,000 | 432,000 | 171,000 | 176,000 | 98,000 |
| Net Income Continuous | 628,000 | 1,062,000 | 472,000 | 373,000 | -54,000 |
| Net Income | $628,000 | $1,062,000 | $472,000 | $373,000 | $-54,000 |
| EPS Basic Total Ops | 0.76 | 1.27 | 0.57 | 0.46 | -0.07 |
| EPS Basic Continuous Ops | 0.76 | 1.27 | 0.57 | 0.46 | -0.07 |
| EPS Diluted Total Ops | 0.75 | 1.24 | 0.56 | 0.45 | -0.07 |
| EPS Diluted Continuous Ops | 0.75 | 1.24 | 0.56 | 0.45 | -0.07 |
| EBITDA(a) | $1,282,000 | $1,849,000 | $893,000 | $771,000 | $332,000 |